Second-quarter net income of the world's largest provider of dialysis treatments came in at 351 million euros (318.33 million pounds), above analysts' average forecast of 325 million euros according to a company-provided poll.

The company confirmed its 2020 targets of mid to high single digit growth in both revenue and net income, based on the neutral net impact from the pandemic it had seen in the first half of the year.

(Reporting by Zuzanna Szymanska and Milla Nissi in Gdansk; Editing by Tomasz Janowski)